Serono Laboratories (UK) Limited Company Profile

00:26 EDT 24th March 2018 | BioPortfolio

We are one of the world’s top three biotechnology companies, with revenues of USD 1.38 billion (2001).

We currently focus on three core therapeutics areas:

Reproductive Health Multiple Sclerosis

Growth & Metabolism

We are also investing strongly in the future, as expressed by our New Therapeutic Areas.

Global reach

We operate in 45 countries and have sales in over 100 countries.


Bedfont Cross, Stanwell road
TW14 8NX
United Kingdom


Phone: +44-20-8818-7200
Fax: +44-20-8818-7222

News Articles [281 Associated News Articles listed on BioPortfolio]

FDA designates orphan status to EMD Serono's gastric cancer drug

Merck KGaA unit EMD Serono's Bavencio, or avelumab, was given orphan drug designation by the FDA to treat patients with gastr -More- 

Merck Serono, WuXi AppTec and Pontifax Form Israeli Life Science Incubator

The incubator will be located at Merck Serono's current facilities in Yavne, a town in central Israel.

Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, in...

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk,...

Dr. Reddy's Laboratories Ltd (RDY) Set to Announce Earnings on Tuesday

Dr. Reddy's Laboratories Ltd will be releasing its earnings data after the market closes on Tuesday, October 31st. Shares of Dr. Reddy's Laboratories Ltd traded down 0.28% during midday tradin...

BRIEF—Multiple sclerosis therapy Mavenclad given green light in Canada

Merck KGaA’s American biotech subsidiary EMD Serono has announced that the Candian medicines regulator…

EMD Serono Appoints U.S. Government & Public Affairs VP

Sussman to lead the company's government policy strategy and advocacy efforts

Buyer Beware: Strategies for Navigating the Antibodies Market

ArticlePoorly characterized antibodies are producing false conclusions and uninterpretable results in laboratories all over the world. But there are steps laboratories can take to validate antibodies ...

PubMed Articles [167 Associated PubMed Articles listed on BioPortfolio]

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.

An online survey of mycology laboratories in seven Asian countries was conducted to assess the status, competence, and services available. Country representatives from the Asia Fungal Working Group (A...

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.

Increasingly used for clinical purposes, genome and exome sequencing can generate clinically relevant information that is not directly related to the reason for testing (incidental or secondary findin...

The American Society for Clinical Pathology's 2016-2017 Vacancy Survey of Medical Laboratories in the United States.

To determine the extent and distribution of workforce shortages within the nation's medical laboratories.

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

Clinical Trials [260 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Purpose of the study is the comparative evaluation of the clinical efficacy and of the general tolerability of two different subcutaneous FSH preparations (Fostimon® IBSA Vs Gonal-F® Ser...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Companies [1052 Associated Companies listed on BioPortfolio]

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

Serono Laboratories Incorporated

We develop innovative products to fight debilitating diseases and improve the lives of our patients.We aspire to create an environment that enables our people to excel and innovate and to contribute t...

Serono Inc.

Serono is a global biotechnology leader with over 4,750 employees and worldwide revenues of USD 2,586.4 million in the year 2005. We have eight biotechnology products on the market and currently more ...

Serono Laboratories (UK) Limited

We are one of the world’s top three biotechnology companies, with revenues of USD 1.38 billion (2001).We currently focus on three core therapeutics areas:Reproductive Health Multiple Sclerosis Growt...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "Serono Laboratories (UK) Limited" on BioPortfolio

We have published hundreds of Serono Laboratories (UK) Limited news stories on BioPortfolio along with dozens of Serono Laboratories (UK) Limited Clinical Trials and PubMed Articles about Serono Laboratories (UK) Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Serono Laboratories (UK) Limited Companies in our database. You can also find out about relevant Serono Laboratories (UK) Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...

Corporate Database Quicklinks

Searches Linking to this Company Record